These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 33692860

  • 1. Forkhead box protein O3a promotes glioma cell resistance to temozolomide by regulating matrix metallopeptidase and β-catenin.
    Sun D, Yang S, Zhang X, Li S, Wang L, Chen J, Qiu C, Xu K.
    Oncol Lett; 2021 Apr; 21(4):328. PubMed ID: 33692860
    [Abstract] [Full Text] [Related]

  • 2. FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation.
    Xu K, Zhang Z, Pei H, Wang H, Li L, Xia Q.
    Oncol Rep; 2017 Apr; 37(4):2391-2397. PubMed ID: 28260024
    [Abstract] [Full Text] [Related]

  • 3. FOXO3a protects glioma cells against temozolomide-induced DNA double strand breaks via promotion of BNIP3-mediated mitophagy.
    He C, Lu S, Wang XZ, Wang CC, Wang L, Liang SP, Luo TF, Wang ZC, Piao MH, Chi GF, Ge PF.
    Acta Pharmacol Sin; 2021 Aug; 42(8):1324-1337. PubMed ID: 33879840
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G.
    Cancer Lett; 2018 Oct 28; 435():66-79. PubMed ID: 30081068
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple Pathway-Dephosphorylated ASK-1 Confers Temozolomide-Resistance to Human Glioma Cells.
    Gao K, She K, Fan J, Shao L, Ji Z.
    Turk Neurosurg; 2024 Oct 28; 34(1):67-73. PubMed ID: 36951032
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT.
    J Hematol Oncol; 2018 May 29; 11(1):70. PubMed ID: 29843746
    [Abstract] [Full Text] [Related]

  • 12. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.
    Li H, Yuan X, Yan D, Li D, Guan F, Dong Y, Wang H, Liu X, Yang B.
    Cell Physiol Biochem; 2017 May 29; 42(3):1192-1201. PubMed ID: 28668966
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W, Yan D, Song Z, Zhu X, Liu X, Li X, Zhao S.
    Life Sci; 2019 Jun 01; 226():98-106. PubMed ID: 30980849
    [Abstract] [Full Text] [Related]

  • 15. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
    Wei J, Qi X, Zhan Q, Zhou D, Yan Q, Wang Y, Mo L, Wan Y, Xie D, Xie J, Yang S.
    Biomed Pharmacother; 2015 Apr 01; 71():112-8. PubMed ID: 25960225
    [Abstract] [Full Text] [Related]

  • 16. Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen.
    Pan Q, Yang XJ, Wang HM, Dong XT, Wang W, Li Y, Li JM.
    Cell Biochem Biophys; 2012 Jan 01; 62(1):185-91. PubMed ID: 21892781
    [Abstract] [Full Text] [Related]

  • 17. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine.
    Stritzelberger J, Distel L, Buslei R, Fietkau R, Putz F.
    Clin Transl Oncol; 2018 Apr 01; 20(4):508-516. PubMed ID: 28825189
    [Abstract] [Full Text] [Related]

  • 18. FoxO3a mediates glioma cell invasion by regulating MMP9 expression.
    Xu K, Pei H, Zhang Z, Dong S, Fu RJ, Wang WM, Wang H.
    Oncol Rep; 2016 Nov 01; 36(5):3044-3050. PubMed ID: 27633065
    [Abstract] [Full Text] [Related]

  • 19. Differentiated embryonic chondrocyte-expressed gene 1 promotes temozolomide resistance by modulating the SP1-MGMT axis in glioblastoma.
    Lv W, Li Q, Jia B, He Y, Ru Y, Guo Q, Li X, Lin W.
    Am J Transl Res; 2021 Nov 01; 13(4):2331-2349. PubMed ID: 34017393
    [Abstract] [Full Text] [Related]

  • 20. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z, Wei X, Shen L, Zhu H, Zheng X.
    Cancer Sci; 2019 Jan 01; 110(1):389-400. PubMed ID: 30431207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.